Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-105.82M
↓ 16% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-91.22M
Historical baseline
PeriodValueYoY Change
2025$-105.82M-22.6%
2024$-86.32M+54.2%
2023$-188.53M-33.1%
2022$-141.65M-95.2%
2021$-72.56M-66.2%
2020$-43.66M-2182800.0%
2019$-2000.00-